PATENT CLAIM ANALYSIS

Application Number: 16043219
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-12
Patent Classification: ["514", "254040"]

Abstract:
The present invention relates to a medicament comprising lurasidone or a pharmaceutically acceptable acid addition salt thereof for treating pervasive developmental disorders and a method of the treatment thereof.

Claim (Index 7):
The method of  claim 2  wherein the mental and behavioural disorder is a congenital disease accompanied by autism-like symptoms.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 95.0
- Lexical Diversity: 1.11111
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13827655', '15892144', '15316110', '13876108', '15004218']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7726458995585244
- 35 USC 102 Novelty (BERT): 0.5610083107582211
- Combined Prediction Score: 0.7514821406784941
- Mean Citation Score: 273.456884
- Max Citation Score: 440.79074
- Similarity Product: 350.59713553082946

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test